The effect of prolonged inhaled nitric oxide on pulmonary vasoconstriction in rats

Anesthesia and Analgesia

Volumn 87, Issue 6, 1998, Pages 1285-1290

  Frank, Deborah U ^a   Horstman, Damian J ^a   Rich, George F ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ANGIOTENSIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; THROMBOXANE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HYPOXIC LUNG VASOCONSTRICTION; ISOLATED LUNG; LUNG CIRCULATION; LUNG PRESSURE; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT;

EID: 0031738125     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-199812000-00014     Document Type: Article

References (25)

1. Mallikharjuna VSN, Karamsetty R, Kane KA, Wadsworth RM. The effects of chronic hypoxia on the pharmacological responsiveness of the pulmonary artery. Pharmacol Ther 1995;68: 233-46.
2. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
3. McDonald LJ, Murad F. Nitric oxide and cyclic GMP signaling. Proc Soc Exp Bio Med 1996;211:1-6.
4. Roos CM, Frank DU, Xue C, et al. Chronic inhaled nitric oxide: effects on pulmonary vascular endothelial function and pathology in rats. J Appl Physiol 1996;80:252-60.
5. Archer SL, Tolins JP, Raij L, Weir EK. Hypoxie pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor. Biochem Biophys Res Comm 1989;164:1198-205.
6. Maramatsu M, Tyler RC, Rodman DM, McMurtry IF. Thapsigargin stimulated increased NO activity in hypoxic hypertensive rat lungs and pulmonary arteries. J Appl Physiol 1996;80:1336-44.
7. Crawley DE, Liu SF, Evans TW, Barnes PJ. Inhibitory role of endothelium-derived relaxing factor in rat and human pulmonary arteries. Br J Pharmacol 1990;101:166-70.
8. Brashers VL, Peach MJ, Rose CE jr. Augmentation of hypoxic pulmonary vasoconstriction in the isolated perfused rat lung by in vitro antagonists of endothelium-dependent relaxation. J Clin Invest 1988;82:1495-502.
9. Rich GF, Murphy GD, Roos CM, Johns RA. Inhaled nitric oxide: selective pulmonary vasodilation in cardiac surgical patients. Anesthesiology 1993;78:1028-35.
10. Roberts JD, Fineman JR, Morin FC, et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl J Med 1997;336:605-10.
11. Atz AM, Adatia I, Wessel DL. Rebound pulmonary hypertension after inhalation of nitric oxide. Ann Thorac Surg 1996;62:1759-64.
12. Lavoie A, Hall JB, Olson DM, Wylam ME. Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure. Am J Respir Crit Care Med 1996;153:1985-7.
13. Assreuy J, Cunha FQ, Liew FY, Moncada S. Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol 1993;180:833-7.
14. Ravichandran LV, Johns RA, Rengasamy A. Direct and reversible inhibition of endothelial nitric oxide synthase by nitric oxide. Am J Physiol 1995;268:H2216-23.
15. Rengasamy A, Johns RA. Regulation of nitric oxide synthase by nitric oxide. Mol Pharmacol 1993;44:124-8.
16. Oka M, Ohnishi M, Takahashi H, et al. Altered vasoreactivity in lungs isolated from rats exposed to nitric oxide gas. Am J Physiol 1996;271:L419-24.
17. Combes X, Mazmanian M, Gourlain H, Hervé P. Effect of 48 hours of nitric oxide inhalation on pulmonary vasoreactivity in rats. Am J Respir Crit Care Med 1997;156:473-7.
18. Frank DU, Horstman DJ, Morris GN, et al. Regulation of the endogenous NO pathway by prolonged inhaled NO in rats. J Appl Physiol 1998;85:1070-8.
19. LeCras TD, Xue C, Rengasamy A, Johns RA. Chronic hypoxia upregulated endothelial and inducible NO synthase gene and protein expression in rat lung. Am J Physiol 1996;270:L164-70.
20. Shaul PW, North AJ, Brannon TS, et al. Prolonged in vivo hypoxia enhanced nitric oxide synthase type I and type III gene expression in adult rat lung. Am J Respir Cell Mol Biol 1995;13:167-74.
21. Xue C, Johns RA. Upregulation of nitric oxide synthase correlates temporally with onset of pulmonary vascular remodeling in the hypoxic rat. Hypertension 1996;28:743-53.
22. McDonald LJ, Murad F. Nitric oxide and cyclic GMP signaling. Proc Soc Exp Biol Med 1996;211:1-6.
23. Kouyoumdjian C, Adnot S, Levame M, et al. Continuous inhalation of nitric oxide protects against the development of pulmonary hypertension in chronically hypoxic rats. J Clin Invest 1994;94:578-84.
24. Roberts JD, Roberts CT, Jones RC, et al. Continuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy, and growth retardation in the hypoxic newborn rat. Circ Res 1995;76:215-22.
25. Steudel W, Scherrer-Crosbie M, Bloch KD, et al. Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3. J Clin Invest 1998;101:2468-77.